Biopharmaceutical Drug Design and Development

- Biotechnology: 2005 and Beyond

- Human Genome Project

- Bioinformatics

- DNA Microarrays in Drug Discovery and Development

- Microarray Technology Using Proteins, Cells, and Tissues

- Pharmacogenetic Issues in Biopharmaceutical Drug Development

- Transgenics

- Therapeutic Gene Delivery

- Stem Cells

- Nucleic Acid Based Therapeutics

- Therapeutic Strategies Targeting the Innate Immune Response

- Pharmacogenetics in the Clinic

- Molecular Modeling: Considerations for the Design of Pharmaceuticals and Biopharmaceuticals

- Macromolecular Drug Delivery

- Changes in Biologic Drug Approval at FDA

- Follow On Protein Products: The Age of Biogenerics?

From the reviews of the second edition:"The book comprises 16 chapters written by 24 authors from academic and industrial laboratories in the U.S. The book is suitable for a wide audience of industrial and academic pharmaceutical scientists interested in a broad introduction to biopharmaceutical technology within the context of drug design and development. ... Overall, the book is well written with an excellent nine-page index. The chapters are generally well illustrated. ... it would be a valuable addition to industrial and academic libraries." (Aliasger K. Salem, Journal of Medicinal Chemistry, Vol. 51 (19), 2008)"This book is an update of the first edition of Biopharmaceutical Drug Development ... . this book is dedicated to quite detailed discussion of the impact the various 'omic' technologies have had on drug discovery and design. ... Overall, this is quite a useful reference book for toxicologists working in the biopharmaceutical sector, particularly if they are still getting to grips with the various 'omics' technologies and areas such stem cell therapy and gene silencing." (Peter Ryle, British Toxicological Society Newsletter, June-August, 2009)